Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (701-710 of 722) with videos related to

Pageof 73
Sort By:
Lancet (London, England)|May 7, 2019
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. Respiratory Medicine|March 19, 2026
Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trialErik H A Michels, Pierre-François Dequin, Joe M Butler, et al.
Nature Communications|December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohortJ Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Lancet (London, England)|January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Nature Medicine|February 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastomaTimothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, et al.
BMC Emergency Medicine|May 13, 2021
Impact of the COVID-19 pandemic on incidence and severity of acute appendicitis: a comparison between 2019 and 2020Jochem C G Scheijmans, Alexander B J Borgstein, Carl A J Puylaert, et al.
Thorax|June 10, 2022
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trialInge A H van den Berk, Maadrika M N P Kanglie, Tjitske S R van Engelen, et al.
Cell Reports. Medicine|May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressureJenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Trials|February 14, 2026
Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trialAnouk G Overdevest, Elske Sieswerda, Sylke Haal, et al.
Pageof 73

Showing results (701-710 of 722) with videos related to

Sort By:
Pageof 73
Lancet (London, England)|May 7, 2019
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyAlison J Rodger, Valentina Cambiano, Tina Bruun, et al.
The Lancet. Respiratory Medicine|March 19, 2026
Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trialErik H A Michels, Pierre-François Dequin, Joe M Butler, et al.
Nature Communications|December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohortJ Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Lancet (London, England)|January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Nature Medicine|February 12, 2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastomaTimothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, et al.
BMC Emergency Medicine|May 13, 2021
Impact of the COVID-19 pandemic on incidence and severity of acute appendicitis: a comparison between 2019 and 2020Jochem C G Scheijmans, Alexander B J Borgstein, Carl A J Puylaert, et al.
Thorax|June 10, 2022
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trialInge A H van den Berk, Maadrika M N P Kanglie, Tjitske S R van Engelen, et al.
Cell Reports. Medicine|May 2, 2025
Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressureJenna J LaBelle, Rebecca D Haase, Alexander Beck, et al.
Trials|February 14, 2026
Antibiotic treatment for 1 day versus 4-7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trialAnouk G Overdevest, Elske Sieswerda, Sylke Haal, et al.
Pageof 73